News
Indroduction: Ara-C (cytarabine) resistance remains a significant contributor to the poor clinical outcomes in adult acute myeloid leukemia (AML). However, predicting Ara-C resistance and developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback